Cellular immunity and herpesvirus infections in cardiac-transplant patients.
about
Incidence and risk factors for herpes zoster following heart transplantation.Comparative analysis of drug action on B-cell proliferation and differentiation for mycophenolic acid, everolimus, and prednisoloneEffect of prostaglandins and cyclic adenosine 3',5'-monophosphate modulators on herpes simplex virus growth and interferon response in human cells.Age-dependent resistance of human alveolar macrophages to herpes simplex virusHerpes latency, meningitis, radiculomyelopathy and disseminated infection.Cell-mediated immunity to varicella-zoster virus measured by virus inactivation: mechanism and blocking of the reaction by specific antibody.Cellular and humoral immune responses to varicella-zoster virus in immunocompromised patients during and after varicella-zoster infectionsProliferative and interferon responses by peripheral blood mononuclear cells after bone marrow transplantation in humans.Cellular and humoral immune responses to herpes simplex virus during and after primary gingivostomatitisRecombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitroOrofacial infection of athymic mice with defined mixtures of acyclovir-susceptible and acyclovir-resistant herpes simplex virus type 1Axonal transport of herpes simplex virions to epidermal cells: evidence for a specialized mode of virus transport and assembly.Alteration of lymphocyte transformation response to herpes simplex virus infection by acyclovir therapy.Short-course human leukocyte interferon in treatment of herpes zoster in patients with cancer.Herpes simplex virus infection of human T-cell subpopulationsTreatment of recurrent herpes simplex labialis with levamisole.Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infectionTolerance and suppression of immunity to herpes simplex virus: different presentations of antigens induce different types of suppressor cellsExternal ocular herpesvirus infections in immunodeficiency.Pathogenesis of herpes simplex labialis: excretion of virus in the oral cavity.Cell-mediated and humoral immune responses to herpes simplex virus and cytomegalovirus in renal transplant patients.Role of T lymphocytes in cellular immune responses during herpes simplex virus infection in humans.Herpesvirus and enteric viral infections in bone marrow transplantation: clinical presentations, pathogenesis, and therapeutic strategies.Antibiotic resistant fever associated with herpes simplex virus infection in neutropenic patients with haematological malignancy.Immunological reactions in heart disease.Herpes simplex virus-infected human fibroblasts are resistant to and inhibit cytotoxic T-lymphocyte activity.Increased susceptibility to herpes simplex virus infections in children with acute measles.Cell-mediated and humoral immunity to herpesviruses during and after herpes zoster infections.Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma.Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults.Seronegative Herpes simplex Associated Esophagogastric Ulcer after Liver Transplantation.A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients.Acyclovir treatment of skin lesions results in immune deviation in mice infected cutaneously with herpes simplex virus.Preparation of stable target cells for anti-herpes simplex virus cytotoxic T lymphocytes.Herpes simplex encephalitis and sarcoidosis.
P2860
Q33637650-1A5104DE-DD03-47E9-9BB6-C0FE3526B76BQ33654680-305283C9-3130-4867-BC36-E607E9288895Q33898085-9837FE3D-7099-45D0-949B-A43D43D76B60Q33902587-910DA61C-DB28-4D60-BD6F-B4B8A6274DF5Q33935057-B4DD37EB-2C93-44F9-BFDF-82FCA0316E99Q34088043-DD458CE8-EF40-4DFF-AAC2-EA96282A4366Q34088091-4E6A3FF9-D535-49E1-92D4-0174F4D500ADQ34447388-534B06CC-C19F-4C4C-8256-CE591AA030A3Q34460442-3082E944-9FEE-4D12-BD8C-2CD5AA65B6B1Q34959913-D250D1A4-AD89-413D-AA30-23C625A80B15Q35244752-A26E951D-B58F-41B4-8A31-B11ACBF2660DQ35580569-426A3A08-188A-4F31-80CF-BB815CD5A228Q35641161-1B7F73D3-5E7A-4F05-B3A8-B150283E0818Q35668580-01D14421-B426-4125-BEFE-D0CD39A1D919Q36338273-B7B24CBE-4F57-47FF-8CA9-DDB70EB1C014Q36480586-FC9C3564-3C92-4BD8-BCE9-36EDB6167677Q36889122-CCDC38CB-2018-44B7-9C14-F7DC6B235656Q37111678-DAB4C15A-65FC-4071-A774-D4141DC079A4Q37221900-78E41803-43E1-4BD3-A97B-047A7692E695Q37263886-442BFA4F-09A7-4AFB-B637-2F122BE43E44Q37317382-56DE9F63-4194-4DE2-B1E7-5B478267F63AQ37593016-DC1344C8-AE6D-4100-A50E-8530F6F58D11Q37901418-1D8CCD63-4D77-4CF7-95F1-8918D0B7084FQ39634295-3E1DF601-EF48-4FA6-BB01-A38E6A0876FBQ39720271-63898386-5D9E-401D-B143-B45CBF979E36Q40060604-94874997-FA0B-42F0-B404-623F8EFA6D9DQ40615823-2C92EF18-2211-458F-AF66-DD37148685CBQ40859939-FC2186A3-9F60-4CDA-9942-93CB105A2FD3Q40969541-1C5E28D5-BA7A-4B67-9591-740F72107130Q42279635-00FFADD2-CD55-4783-9D8E-9B93B5DD1EF3Q42715323-AA885106-61D9-43A4-B630-187D947F53DEQ43567469-E244C1A1-05CA-4189-BDFD-4E82F3FAE7F7Q43858440-EAA2EF01-1FBE-4795-8DAF-C0B5E33B6371Q45806467-C06C8F25-3C09-453F-B370-68AA7203B390Q48105799-9B0E2E0F-9331-442C-A7E8-2F45A84F9A6C
P2860
Cellular immunity and herpesvirus infections in cardiac-transplant patients.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh
1977年學術文章
@zh-hant
name
Cellular immunity and herpesvirus infections in cardiac-transplant patients.
@en
type
label
Cellular immunity and herpesvirus infections in cardiac-transplant patients.
@en
prefLabel
Cellular immunity and herpesvirus infections in cardiac-transplant patients.
@en
P2093
P1476
Cellular immunity and herpesvirus infections in cardiac-transplant patients.
@en
P2093
P304
P356
10.1056/NEJM197706162962402
P407
P577
1977-06-01T00:00:00Z